Particle Charging Using Ultra-Short Pulse Laser in the Ideal Maxwellian Cold Plasma for Cancer Treatment Based on Hadron Therapy
Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), ISSN: 1611-3349, Vol: 11620 LNCS, Page: 767-784
2019
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Conference Paper Description
In biomedicine the utilization of accelerators, enables the arrangements of mixes to be utilized in cancer treatment. Accelerators are the standout among the most imperative uses of the electric and attractive fields manage the movement of charged particles. Additionally, the investigation of the plasma requires the examination of the charged particle movements in an electromagnetic field. The laser driven acceleration of particles is a standout among the most critical utilization of the laser plasma interaction. This plan depends on the alteration of the laser electromagnetic field into the plasma wave. These high stage velocity plasma waves can trap and quicken plasma electrons to exceptionally high energies. The plasma condition of issue might be characterized as a blend of decidedly charged ions, electrons and impartial atoms which comprises a perceptible electrically unbiased medium which reacts to the electric and attractive fields in an aggregate mode. In ideal Maxwellian plasma, the energy distribution function of charged particles is Maxwellian and subordinates from Maxwell-Boltzmann distribution. Cold plasma spoke to extremely helpful apparatuses empowering interaction with organic tissue without the warm harm and this innovation improvement brought about the quick formation of another field of plasma medication. Consequently, Hadron therapy is a high-precision procedure in cancer radiation therapy, which permits getting a better conformal treatment with deference than conventional radiation therapy strategies which depends on particle accelerating. This paper surveys on ions importance as charged particles with ultra-short pulse laser in an ideal Maxwellian cold plasma due to cancer treatment via Hadron therapy.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85069180024&origin=inward; http://dx.doi.org/10.1007/978-3-030-24296-1_61; http://link.springer.com/10.1007/978-3-030-24296-1_61; http://link.springer.com/content/pdf/10.1007/978-3-030-24296-1_61; https://dx.doi.org/10.1007/978-3-030-24296-1_61; https://link.springer.com/chapter/10.1007/978-3-030-24296-1_61
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know